A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
Clinical trial NCT03261947 · COMPLETED
Trial details
- NCT number
- NCT03261947
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2020-08-24
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.